Universitätsklinikum Hamburg-Eppendorf, III Medizinische Klinik, Martinistrasse 52, 20246 Hamburg, Germany.
J Am Soc Nephrol. 2012 Sep;23(9):1486-95. doi: 10.1681/ASN.2012010040. Epub 2012 Jul 12.
The Th17 immune response appears to contribute to the pathogenesis of human and experimental crescentic GN, but the cell types that produce IL-17A in the kidney, the mechanisms involved in its induction, and the IL-17A-mediated effector functions that promote renal tissue injury are incompletely understood. Here, using a murine model of crescentic GN, we found that CD4(+) T cells, γδ T cells, and a population of CD3(+)CD4(-)CD8(-)γδT cell receptor(-)NK1.1(-) T cells all produce IL-17A in the kidney. A time course analysis identified γδ T cells as a major source of IL-17A in the early phase of disease, before the first CD4(+) Th17 cells arrived. The production of IL-17A by renal γδ T cells depended on IL-23p19 signaling and retinoic acid-related orphan receptor-γt but not on IL-1β or IL-6. In addition, depletion of dendritic cells, which produce IL-23 in the kidney, reduced IL-17A production by renal γδ T cells. Furthermore, the lack of IL-17A production in γδ T cells, as well as the absence of all γδ T cells, reduced neutrophil recruitment into the kidney and ameliorated renal injury. Taken together, these data suggest that γδ T cells produce IL-17A in the kidney, induced by IL-23, promoting neutrophil recruitment, and contributing to the immunopathogenesis of crescentic GN.
Th17 免疫反应似乎有助于人类和实验性新月体性肾小球肾炎的发病机制,但在肾脏中产生 IL-17A 的细胞类型、其诱导的机制以及促进肾脏组织损伤的 IL-17A 介导的效应功能尚不完全清楚。在这里,我们使用新月体性肾小球肾炎的小鼠模型发现,CD4(+)T 细胞、γδ T 细胞和一群 CD3(+)CD4(-)CD8(-)γδT 细胞受体(-)NK1.1(-)T 细胞都在肾脏中产生 IL-17A。时间进程分析表明,γδ T 细胞是疾病早期(第一批 CD4(+)Th17 细胞到达之前)IL-17A 的主要来源。肾脏 γδ T 细胞产生 IL-17A 依赖于 IL-23p19 信号和维甲酸相关孤儿受体-γt,但不依赖于 IL-1β 或 IL-6。此外,肾脏中产生 IL-23 的树突状细胞的耗竭减少了肾脏 γδ T 细胞产生的 IL-17A。此外,γδ T 细胞缺乏 IL-17A 产生以及缺乏所有 γδ T 细胞均减少了中性粒细胞向肾脏的募集并改善了肾脏损伤。综上所述,这些数据表明,肾脏中的 γδ T 细胞在 IL-23 的诱导下产生 IL-17A,促进中性粒细胞募集,并有助于新月体性肾小球肾炎的免疫发病机制。